Corwin A. Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, & Philipp Oster. (2024). Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age. Taylor & Francis Group.
Chicago Style (17th ed.) CitationCorwin A. Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, and Philipp Oster. Immune Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) 5 Years After Primary Vaccination of Adults at ≥56 Years of Age. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationCorwin A. Robertson, et al. Immune Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) 5 Years After Primary Vaccination of Adults at ≥56 Years of Age. Taylor & Francis Group, 2024.